Synapse

← Deepak L. Bhatt

Papers by Deepak L. Bhatt

Page 1 · newest first

  1. Coronary Artery Bypass Graft Failure in WomenJournal of the American College of Cardiology · 2024
  2. Moving Toward Global Primordial Prevention in Cardiovascular DiseaseJournal of the American College of Cardiology · 2015
  3. The Rise and Fall and Rise of Renal DenervationJournal of the American College of Cardiology · 2022
  4. Clinical Safety Evaluation of a Large Language Model for Heart Failure Treatment RecommendationsJournal of the American College of Cardiology · 2026
  5. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection FractionJournal of the American College of Cardiology · 2017
  6. Beyond the HORIZON: does knowing Lp(a) change what we do?European Journal of Preventive Cardiology · 2026
  7. Multimodality Cardiac Imaging Substudy of the DAPT-SHOCK-AMI Randomized Trial: Echocardiographic and Cardiac Magnetic Resonance Assessment of Cangrelor versus Crushed Ticagrelor in Cardiogenic Shock Complicating Acute Myocardial InfarctionCirculation · 2026
  8. Common Genetic Variants Near SLC2A2 and Glycemic Response to Glimepiride in the GRADE Comparative Effectiveness Clinical TrialDiabetes Care · 2026
  9. What we know from Lp(a)HORIZON and what remains unknownProgress in Cardiovascular Diseases · 2026
  10. The ADIPO-CARE Plan: A Comprehensive Implementation Framework for the Diagnosis and Management of People Living with Obesity—Experts’ ProposalNutrients · 2026
  11. Long-Term Outcomes of Endoscopic or Open Vein Harvesting for Coronary Artery Bypass Grafting: A 10-Year Follow-Up of the REGROUP Randomized Clinical TrialCirculation · 2026
  12. Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary StentingJournal of the American College of Cardiology · 2017
  13. Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.2026
  14. Cortisol in cardio-kidney-metabolic diseaseEuropean Heart Journal · 2026
  15. ESC Congress 2026 Antithrombotic Highlights: Balancing Ischemic and Bleeding Risk After Percutaneous InterventionEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2026
  16. Cardiovascular Risk and Statin Eligibility of Young Adults After an MIJournal of the American College of Cardiology · 2017
  17. ACCF 2012 Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin ElevationsJournal of the American College of Cardiology · 2012
  18. Cardiovascular Implications of Hypoglycemia in Diabetes MellitusCirculation · 2015
  19. ACCF/AHA Clinical Practice Guideline Methodology Summit ReportCirculation · 2012
  20. Parsing the Adipokine Axis in HFpEFJournal of the American College of Cardiology · 2025
  21. Risks of Overinterpreting Interim DataCirculation · 2018
  22. Preventive Cardiology as a Subspecialty of Cardiovascular MedicineJournal of the American College of Cardiology · 2019
  23. Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft OcclusionJournal of the American College of Cardiology · 2019
  24. Transcatheter Aortic Valve Replacement Beyond Severe Aortic StenosisJournal of the American College of Cardiology · 2025
  25. A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular RiskJournal of the American College of Cardiology · 2025
  26. Outcomes in patients with diabetes, atherosclerotic cardiovascular disease, and heart failure treated with tirzepatide or dulaglutide: SURPASS-CVOT analysisEuropean Journal of Preventive Cardiology · 2026
  27. Cost-Effectiveness of Sotagliflozin in Heart Failure Patients with Preserved and Reduced Ejection Fractions – Results from SOLOIST-WHFThe American Journal of Cardiology · 2026
  28. Associations Between Central Adiposity Measures and Subclinical Coronary Artery Calcification and Progression of Disease: A Collaborative Meta-Analysis of 49 Cohorts and 68,629 ParticipantsHeart Lung and Circulation · 2026
  29. Risk-Weighted Apob Outperforms Traditional Lipid Biomarkers in Predicting Residual Cardiovascular Risk in Statin-Treated Hypertriglyceridemic Patients: Post Hoc Analysis of the Reduce-It Placebo ArmAtherosclerosis · 2026
  30. Target versus below-target dose ACE inhibitors in US veterans with HFpEF: differential outcomes by CKD statusEuropean Journal of Heart Failure · 2026
  31. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trialsThe Lancet · 2023
  32. Benefit of Early Invasive Therapy in Acute Coronary SyndromesJournal of the American College of Cardiology · 2006
  33. Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients With HypertensionJournal of the American College of Cardiology · 2019
  34. Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine DiphosphateJournal of the American College of Cardiology · 2010
  35. Does SGLT1 Inhibition Add Benefit to SGLT2 Inhibition in Type 2 Diabetes?Circulation · 2021
  36. The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethylEuropean Heart Journal · 2021
  37. Intracoronary Imaging-Guided Percutaneous Coronary InterventionJournal of the American College of Cardiology · 2026
  38. Divergent Cardiac and Renal Outcomes by Systolic Blood Pressure in HFrEFThe American Journal of Medicine · 2026
  39. Comparative risk assessment of cardiovascular and kidney outcomes in patients with type 2 diabetes using cystatin C and creatinine in DECLARE-TIMI 58American Heart Journal Plus Cardiology Research and Practice · 2026
  40. Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMESCirculation · 2025
  41. Sex Disparities in ACC Late-Breaking Cardiovascular TrialsJACC Advances · 2026
  42. Vascular Regenerative Cell Deficiencies in South Asian AdultsJournal of the American College of Cardiology · 2024
  43. 0055Prevalence of Endogenous Hypercortisolism in Individuals With Resistant Hypertension Stratified by Kidney Function: Results From the MOMENTUM StudyAmerican Heart Journal · 2026
  44. Randomized Trials Versus Common Sense and Clinical ObservationJournal of the American College of Cardiology · 2020
  45. Persistent C-reactive protein elevation and incident heart failure in adults at increased cardiovascular risk: A multinational electronic health record studyInternational Journal of Cardiology · 2026
  46. Five-Year Follow-Up of Transcatheter Aortic Valve Replacement With Self-Expanding Intra-Annular Versus Commercially Available ValvesJACC: Cardiovascular Interventions · 2026
  47. Mitral Regurgitation and Severe Aortic Stenosis: Clinical Characteristics, Prognostic Impact, and Response to TAVR: Insights From Egnite DataCirculation Cardiovascular Interventions · 2026
  48. Bridging Antiplatelet Therapy After Percutaneous Coronary InterventionJournal of the American College of Cardiology · 2021
  49. Ross Procedure in Adults for Cardiologists and Cardiac SurgeonsJournal of the American College of Cardiology · 2018
  50. Cardiopulmonary Impact of Particulate Air Pollution in High-Risk PopulationsJournal of the American College of Cardiology · 2020